1361386-48-2

Basic information

• Product Name: 3-{[(3-bromo-2-methylphenyl)amino]methyl}-5-(tert-butyl)thiophene-2-carboxylic acid
• Synonyms: 3-{[(3-bromo-2-methylphenyl)amino]methyl}-5-(tert-butyl)thiophene-2-carboxylic acid
• CAS NO: 1361386-48-2
• Molecular Weight: 382.321
• Mol File: 1361386-48-2.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 3-{[(3-bromo-2-methylphenyl)amino]methyl}-5-(tert-butyl)thiophene-2-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-{[(3-bromo-2-methylphenyl)amino]methyl}-5-(tert-butyl)thiophene-2-carboxylic acid(1361386-48-2)
• EPA Substance Registry System: 3-{[(3-bromo-2-methylphenyl)amino]methyl}-5-(tert-butyl)thiophene-2-carboxylic acid(1361386-48-2)

Safety Data

• Hazardous Substances Data: 1361386-48-2(Hazardous Substances Data)

Upstream product

• 1361386-47-1 methyl 3-{[(3-bromo-2-methylphenyl)amino]methyl}-5-(tert-butyl)thiophene-2-carboxylate 
• 1361386-46-0 3-bromomethyl-5-tert-butylthiophene-2-carboxylic acid methyl ester 
• 1361386-45-9 5-tert-butyl-3-methylthiophene-2-carboxylic acid methyl ester 
• 81452-54-2 methyl 3-methylthiophene-2-carboxylate 
• 61341-26-2 3-methylthenoyl chloride 

Downstream Products

• 1361386-50-6 2-(tert-butyl)-5-[2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4H-thieno[2,3-c]pyrrol-6(5H)-one 
• 1361940-93-3 2-tert-butyl-5-(2-methyl-3-(4-methyl-6-(4-(4-methyl-3-oxopiperazin-2-yl)phenylamino)-5-oxo-4,5-dihydropyrazin-2-yl)phenyl)-4H-thieno[2,3-c]pyrrol-6(5H)-one 
• 1361940-92-2 tert-butyl 2-(4-(6-(3-(2-tert-butyl-6-oxo-4H-thieno[2,3-c]pyrrol-5(6H)-yl)-2-methylphenyl)-4-methyl-3-oxo-3,4-dihydropyrazin-2-ylamino)phenyl)-4-methyl-3-oxopiperazine-1-carboxylate 
• 1361940-27-3 2-tert-butyl-5-(2-methyl-3-(4-methyl-6-(4-(1-methyl-3-oxopiperazin-2-yl)phenylamino)-5-oxo-4,5-dihydropyrazin-2-yl)phenyl)-4H-thieno[2,3-c]pyrrol-6(5H)-one 

Relevant articles and documents

NOVEL TRIAZINE DERIVATIVE

To provide a novel triazine derivative represented by the following formula (I): A triazine derivative represented by the following formula (I) : wherein R1 represents a substituted or unsubstituted aryl group, a substituted or unsubstituted he

PYRIDINONES/PYRAZINONES, METHOD OF MAKING, AND METHOD OF USE THEREOF

Pyridone and pyrazinone compounds of Formula (I) including stereoisomers, tautomers, and pharmaceutically acceptable salts thereof, useful for inhibiting Btk kinase, and for treating immune disorders such as inflammation mediated by Btk kinase. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, and treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.